This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignees: Indiana University, The Jackson Laboratory. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 810 
1 out of 98 
Years Active: 2024
Title: Gregory Carter: Innovator in Alzheimer's Research
Introduction
Gregory Carter is a notable inventor based in Bar Harbor, ME (US). He has made significant contributions to the field of Alzheimer's research through his innovative work in genetic engineering.
Latest Patents
Carter holds a patent for a genetically modified mouse expressing human APOE4 and mouse Trem2 p.R47H. This invention provides a model for studying non-familial late-onset Alzheimer's disease. The genetically modified mice exhibit symptoms associated with the expression of human APOE4 protein and mouse Trem2 protein, which are crucial for screening compounds for potential treatments for Alzheimer's disease.
Career Highlights
Throughout his career, Gregory Carter has worked with prestigious institutions such as Indiana University and The Jackson Laboratory. His research has focused on developing models that can aid in understanding and treating Alzheimer's disease.
Collaborations
Carter has collaborated with notable colleagues, including Michael Sasner and Bruce Lamb, to advance research in the field of neurodegenerative diseases.
Conclusion
Gregory Carter's innovative work in creating genetically modified mice has opened new avenues for Alzheimer's research and potential treatments. His contributions are invaluable to the scientific community and the ongoing fight against this devastating disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile